InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Oki Mark K, Chief Financial Officer. Director active across 2 companies, notably Aytu Biopharma, INC. Aggregated, 5 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €47k. History available since 17 January 2022. The latest transaction was disclosed on 18 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Oki Mark K is the Chief Financial Officer of AYTU BIOPHARMA, INC. He is responsible for the financial management of the company, including budgeting, financial analysis, and investment management. His expertise is essential in ensuring the financial viability and growth of the company in the biopharmaceutical sector. He plays a key role in financial strategy and decision-making.